Search

for
Search:

GlossaryRisperidone (Risperdal)

antipsychotic medication used to treat schizophrenia and bipolar disorder

Risperidone, also known by the brand name Risperdal, is an antipsychotic medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and irritability associated with autism. It works by altering the effects of certain chemicals in the brain, particularly dopamine and serotonin, to help stabilize mood and behavior.

Related Terms

Sort by

Research

9 / 9 results

research Drug-Induced Gynecomastia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

4 citations, December 2021 in “Archivio italiano di urologia andrologia”

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

research Diffuse Hair Loss Associated With Hyperprolactinaemia: Report of Three Cases

2 citations, February 2014 in “Journal of the European Academy of Dermatology and Venereology”

High levels of prolactin in the blood can be linked to widespread hair loss.

research Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone

2 citations, May 2013 in “The primary care companion for CNS disorders”

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

research Psychological Interventions in the Management of Common Skin Conditions

41 citations, March 2010 in “Psychology Research and Behavior Management”

Using psychological treatments can help manage skin conditions along with regular medical care.

research Psychodermatology: The Intersection of Dermatology and Psychiatry

25 citations, January 2015 in “Advances in Psychosomatic Medicine”

Many skin patients also have mental health issues, and doctors should treat both together.

research Compilation of a Comprehensive Gene Panel for Systematic Assessment of Genes That Govern an Individual’s Drug Responses

13 citations, October 2010 in “Pharmacogenomics”

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

research Update on Psychodermatological Disorders

5 citations, February 2010 in “Expert Review of Dermatology”

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

research Reporting on Adverse Clinical Events

March 2021 in “Clin-Alert”

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

research Clinical Review of Ejaculatory Dysfunction

24 citations, July 2019 in “Reproductive Medicine and Biology”

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.